14/05/2019 17:30:00

UK Annual Report and Notice of AGM

Summit Therapeutics plc 

(‘Summit’ or the ‘Company’)

Publication of UK Annual Report and Notice of Annual General Meeting

Oxford, UK,

and Cambridge, MA, US, 14 May 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), announces that its Annual Report and Accounts for the year ended 31 January 2019, together with the Notice of Annual General Meeting, have today been sent to shareholders. Copies of both documents are available on the Company’s website, www.summitplc.com.

The Annual General Meeting will be held at 10:00am BST on 19 June 2019 at Pewterers’ Hall, Oat Lane, London, EC2V 7DE.

About Summit Therapeutics

Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for infections caused by C. difficile,N. gonorrhoeae and ESKAPE pathogens and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.

Contacts

Summit

 

 

Glyn Edwards / Richard Pye (UK office)

Tel:

44 (0)1235 443 951
Michelle Avery (US office)

 

+1 617 225 4455

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

Tel:

+44 (0)20 7213 0880
Liam Murray / Tony Rawlinson

 

 

 

 

 

N+1 Singer (Joint Broker)

Tel:

+44 (0)20 7496 3000
Aubrey Powell / Jen Boorer, Corporate Finance

Tom Salvesen, Corporate Broking

 

 

 

 

 

Bryan Garnier & Co Limited (Joint Broker)

Tel:

+44 (0)20 7332 2500
Phil Walker / Dominic Wilson

 

 

 

MSL Group (US)

Tel:

+1 781 684 6557
Jon Siegal

 

summit@mslgroup.com

 

 

 

Consilium Strategic Communications (UK)

Tel:

+44 (0)20 3709 5700
Mary-Jane Elliott / Sue Stuart / Jessica Hodgson /

 

summit@consilium-comms.com

Lindsey Neville

 

 

-END-

Summit Master_rgb_png.png

Related content
18 Sep - 
Summit Announces Publication of Editorial in Future Mic..
05 Sep - 
Summit Presented In Vivo Proof of Concept Data for Targ..
04 Sep - 
Summit Therapeutics to Participate in Upcoming Investor..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 September 2019 07:36:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB4 - 2019-09-22 08:36:27 - 2019-09-22 07:36:27 - 1000 - Website: OKAY